文献速递慢性肾脏病

步态异常与CKD患者跌倒风险

Gait Abnormalities and the Risk of Falls in CKD.
PubMed 文献 · Clin J Am Soc Nephrol · 2019-06-24

本研究在330名≥65岁无残疾社区居住成人中开展定量与临床步态评估,CKD定义为eGFR<60 ml/min per 1.73 m2。结果显示CKD患者存在步态周期异常,且低eGFR与步态异常严重程度独立相关;由短步幅和明显摇晃或失衡定义的步态表型与CKD患者跌倒风险升高相关。

要点

  • CKD患者步态异常包括步幅缩短、站立相和双支撑相时间增加。
  • 低eGFR与步态周期异常严重程度独立相关,并介导步速减慢。
  • CKD合并步态表型者跌倒风险升高,交互作用P=0.01。

核心结论

  • 老年CKD患者存在定量步态异常,临床表现为与跌倒风险相关的步态表型。

研究设计与样本

  • 在330名≥65岁无残疾社区居住成人中行定量和临床步态评估,CKD定义为eGFR<60 ml/min per 1.73 m2,采用Cox比例风险模型分析跌倒风险。

主要发现

  • 41%(n=134)的参与者有CKD,除步速较慢外还存在步幅缩短、站立相和双支撑相时间增加等步态周期异常。
  • 在CKD患者中,eGFR每降低10 ml/min per 1.73 m2,步幅缩短3.6 cm(95%CI 1.4至5.8),摆动相时间减少0.7%(95%CI 0.3至1.0),双支撑相时间增加1.1%(95%CI 0.5至1.7)。
  • 上述步态异常介导了低eGFR与步速减慢的关联。
  • 临床步态检查中,CKD患者短步幅和明显摇晃或失衡更常见,但多数无明确步态表型。
  • 在CKD患者中,由上述异常体征定义的步态表型与跌倒风险升高相关:与无CKD且无步态表型者相比,CKD伴步态表型者的校正HR为1.72(95%CI 1.06至2.81),CKD不伴步态表型者的校正HR为0.71(95%CI 0.40至1.25),CKD状态与步态表型交互作用P=0.01。

临床怎么用

  • 对老年CKD患者应关注步态异常(如短步幅、摇晃或失衡),其与跌倒风险升高相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Older adults with CKD are at high risk of falls and disability. It is not known whether gait abnormalities contribute to this risk. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Quantitative and clinical gait assessments were performed in 330 nondisabled community-dwelling adults aged ≥65 years. CKD was defined as an eGFR <60 ml/min per 1.73 m2. Cox proportional hazards models were created to examine fall risk. RESULTS: A total of 41% (n=134) of participants had CKD. In addition to slower gait speed, participants with CKD had gait cycle abnormalities including shorter stride length and greater time in the stance and double-support phases. Among people with CKD, lower eGFR was independently associated with the severity of gait cycle abnormalities (per 10 ml/min per 1.73 m2 lower eGFR: 3.6 cm [95% confidence interval (95% CI), 1.4 to 5.8] shorter stride length; 0.7% [95% CI, 0.3 to 1.0] less time in swing phase; 1.1% [95% CI, 0.5 to 1.7] greater time in double-support phase); these abnormalities mediated the association of lower eGFR with slower gait speed. On clinical gait exam, consistent with the quantitative abnormalities, short steps and marked swaying or loss of balance were more common among participants with CKD, yet most had no identifiable gait phenotype. A gait phenotype defined by any of these abnormal signs was associated with higher risk of falls among participants with CKD: compared with people without CKD and without the gait phenotype, the adjusted hazard ratio was 1.72 (95% CI, 1.06 to 2.81) for those with CKD and the phenotype; in comparison, the adjusted hazard ratio was 0.71 (95% CI, 0.40 to 1.25) for people with CKD but without the phenotype (P value for interaction of CKD status and gait phenotype =0.01). CONCLUSIONS: CKD in older adults is associated with quantitative gait abnormalities, which clinically manifest in a gait phenotype that is associated with fall risk.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Tran J, Ayers E, Verghese J, et al. Gait Abnormalities and the Risk of Falls in CKD. Clin J Am Soc Nephrol. 2019. PMID: 31235462. doi:10.2215/CJN.13871118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。